Home
About
FAQ
History (18)
Oxidative stress-induced dysregulation of excitation-contraction coupling contributes to muscle weakness.
Principal Investigator
Proteinase Inhibitory Proteins, Secretory
RABL6A promotes G1-S phase progression and pancreatic neuroendocrine tumor cell proliferation in an Rb1-dependent manner.
Selecting disease-modifying medications in 5q spinal muscular atrophy.
See All 18 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Selecting disease-modifying medications in 5q spinal muscular atrophy.
Cartwright MS, Upadhya S. Selecting disease-modifying medications in 5q spinal muscular atrophy. Muscle Nerve. 2021 Oct; 64(4):404-412.
View in:
PubMed
subject areas
Animals
Azo Compounds
Biological Products
Humans
Muscular Atrophy, Spinal
Neuromuscular Agents
Oligonucleotides
Oligonucleotides, Antisense
Pyrimidines
Recombinant Fusion Proteins
Treatment Outcome
authors with profiles
Michael S. Cartwright MD